Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dunaliella Bardawil in Plaque Type Psoriasis Treated by Narrow Band UVB Therapy
NCT01121081Phase 3Withdrawn
- Sponsor
- Sheba Medical Center
- Start
- Jan 2010
- Primary completion
- Jan 2011
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
A Phase 3 trial of Dunaliella bardawil in psoriasis, sponsored by Sheba Medical Center. Planned start Jan 2010; status: withdrawn.
02
Drugs
Dunaliella bardawil
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT01121081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01121081.